Latest Breaking News On - Dayao zhao - Page 1 : comparemela.com

AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery

SHANGHAI, Oct. 31, 2023 /PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing

South koreaDayao zhaoOcular therapeutix incAffamed therapeuticsReal world studyBoao lecheng pilot zoneOcular therapeutixGreater chinaAmed therapeutics

Ocular Therapeutix (OCUL) Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA in Patients after Cataract Surgery

Ocular Therapeutix (OCUL) Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA in Patients after Cataract Surgery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South koreaDayao zhaoOcular therapeutix incAffamed therapeuticsReal world studyLecheng pilot zoneOcular therapeutix

Ocular Therapeutix Shares Rise 15% After Dextenza Trial In China

By Ben Glickman Shares of Ocular Therapeutix rose Tuesday after a trial of its drug Dextenza met its primary endpoint. The stock was up 15% to $2.85 in.

Ben glickmanDayao zhaoOcular therapeutixAmed therapeuticsMed chief executive dayao zhaoArticle normalHealthcare life sciencesSpecialized drugs medicationsFinancial performanceShare price movement disruptionsNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingEquity markets

AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical,.

Hong kongDayao zhaoHanmi pharmaceuticalsAffamed therapeutics ltdChina national medical products administrationDrug administrationAllegro ophthalmicHanmi pharmaceutical co ltdAmed therapeuticsNational medical products administrationClinical trial applicationIntermediate dry age related macular degenerationAffamed therapeuticsGreater chinaIntermediate drySpecial protocol assessment

AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder

AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesShawn singhDayao zhaoWellness surveyWorld mental health survey initiativeNational healthSubjective unitsDistress scaleClinical global impressions improvementAffamed therapeuticsVistagen therapeuticsChief executive officerGlobal impressionLiebowitz social anxiety scaleAmed therapeutics